High costs of orphan drugs: Patients pay the price for policy hurdles in India

Image

India manufactures APIs for over 400 FDA-approved orphan drugs, but patients face high costs due to Indian pharma companies' reluctance to develop these drugs domestically.

You Might Also Like...

0 Comments

Leave a Comment

Post Comment ⇾

Sign Up for Our Newsletter

Subscribe now to get notified about exclusive offers
from The .... every week!